Citizen Petition from Attorney General of Massachusetts, et al.
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from Attorney General of Massachusetts, et al.
- Posted
- Jun 6, 2025
- Comment period
- Jun 6, 2025 – ?
- Topics
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Uncheck an issue to choose another.
| Organization | Mifepristone safety requirements | Telehealth access to medication abortion | Telehealth prescribing | Environmental impact of mifepristone | Impact on ipv survivors |
|---|---|---|---|---|---|
FemInEM AdvocacySupport FemInEM, a non-profit organization focused on reproductive healthcare in emergency departments, supports the petition to | · | · |
15 organization-typed comments could not be identified.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jul 1, 2026Comment from FemInEMSupportAdvocacy📎 Attachment
FemInEM, a non-profit organization focused on reproductive healthcare in emergency departments, supports the petition to remove the Mifepristone Shared System REMS. They argue that mifepristone is safe and effective, and that emergency department visits following its use are often for non-urgent reasons or due to systemic healthcare barriers rather than drug safety issues.
Read comment → - Oct 22, 2025Comment from Center for Telehealth and eHealth LawOpposeAdvocacy📎 Attachment
The Center for Telehealth and eHealth Law (CTeL) argues that telehealth is as effective as in-person care and is a vital tool for expanding healthcare access, particularly in underserved areas. They urge the FDA to refrain from placing restrictions on clinicians' ability to prescribe medication via telehealth, asserting that such restrictions would hinder care and be inconsistent with clinical evidence.
Read comment → - Aug 19, 2025Comment from Jane GilroyOpposeIndividualRead comment →
